Accueil > Actualité
Actualite financiere : Actualite bourse

Novartis: to acquire rights to antifungal agent

( - Sandoz, Novartis' generics and biosimilars division, today announced that it has signed an agreement to acquire the worldwide rights to the systemic antifungal agent Mycamine (Funguard in Japan), from Astellas.

The group said that this will be an important addition to its growing portfolio of anti-infective therapies aimed at combating the spread of antimicrobial resistance by providing the right drug to the right patient at the right time.

Mycamine posted sales of 18.9 billion yen ($135m) for the year ended 31 March 2022. The transaction is expected to close in H1 2023, subject to standard conditions and regulatory approvals.

Copyright (c) 2023 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.